NZ716472A - Infectious bronchitis vaccines derived from ib-qx-like strains - Google Patents
Infectious bronchitis vaccines derived from ib-qx-like strainsInfo
- Publication number
- NZ716472A NZ716472A NZ716472A NZ71647209A NZ716472A NZ 716472 A NZ716472 A NZ 716472A NZ 716472 A NZ716472 A NZ 716472A NZ 71647209 A NZ71647209 A NZ 71647209A NZ 716472 A NZ716472 A NZ 716472A
- Authority
- NZ
- New Zealand
- Prior art keywords
- infectious bronchitis
- strains
- vaccines derived
- bronchitis vaccines
- derived
- Prior art date
Links
- 206010006451 bronchitis Diseases 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000002458 infectious effect Effects 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8722808P | 2008-08-08 | 2008-08-08 | |
NZ62393709 | 2009-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ716472A true NZ716472A (en) | 2017-08-25 |
Family
ID=59742260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ716472A NZ716472A (en) | 2008-08-08 | 2009-08-07 | Infectious bronchitis vaccines derived from ib-qx-like strains |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ716472A (en) |
-
2009
- 2009-08-07 NZ NZ716472A patent/NZ716472A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021006342A (en) | Influenza virus mutants and uses therefor. | |
TN2011000628A1 (en) | Production of polio virus at high titres for vaccine production | |
NZ597182A (en) | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response | |
PH12017500962A1 (en) | Novel european prrsv strain | |
WO2012033328A3 (en) | Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells | |
MY163972A (en) | Attenuated recombinant newcastle disease virus and vaccine containing the same | |
NZ602201A (en) | A novel ethanologenic clostridium species, clostridium coskatii | |
AR077916A1 (en) | MICROORGANISMS (TRAVSTOCHYTRIUM AND SCHIZOCHYTRIUM) EICOSAPENTENOIC ACID PRODUCERS, FATTY ACID COMPOSITIONS, AND METHODS OF ELABORATION AND USE OF THE SAME | |
NZ596856A (en) | Pepper hybrid ps09943431 | |
MX2012005782A (en) | Lyophilization methods, compositions, and kits. | |
MX2012002365A (en) | Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses. | |
MX2009006469A (en) | Method for replicating influenza virus in culture. | |
AU2015204503A8 (en) | Novel vaccines against HPV and HPV-related diseases | |
WO2010001409A3 (en) | Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same | |
NZ611531A (en) | Bovine viral diarrhea virus type 1b vaccine compositions and methods | |
WO2009080806A3 (en) | Modified influenza virus | |
WO2011080271A3 (en) | Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof | |
WO2011064664A3 (en) | T cell receptors specific for immunodominant ctl epitopes of hcv | |
MX339731B (en) | Infectious bronchitis vaccines derived from ib-qx-like strains. | |
MY158665A (en) | Method for converting carbon and hydrocarbon cracking and apparatus for hydrocarbon cracking | |
NZ716472A (en) | Infectious bronchitis vaccines derived from ib-qx-like strains | |
MX2012002702A (en) | Bovine herpesvirus vaccine. | |
EP2593548A4 (en) | Human papillomavirus e7 antigen compositions and uses thereof | |
UA100849C2 (en) | Normal;heading 1;heading 2;heading 3;METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE | |
WO2011077309A3 (en) | Vaccine compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 07 AUG 2019 BY AJ PARK Effective date: 20180111 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 AUG 2020 BY THOMSON REUTERS Effective date: 20190725 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 AUG 2021 BY THOMSON REUTERS Effective date: 20200721 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 AUG 2022 BY THOMSON REUTERS Effective date: 20210702 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 AUG 2023 BY THOMSON REUTERS Effective date: 20220704 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 AUG 2024 BY THOMSON REUTERS Effective date: 20230703 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 AUG 2025 BY THOMSON REUTERS Effective date: 20240702 |